Publication | Closed Access

Asymmetric synthesis of (−)-fosfomycin and its trans-(1S,2S)-diastereomer using a biocatalytic reduction as the key step

Key StepEngineeringBiochemistryAsymmetric SynthesisBiocatalytic ReductionOrganic ChemistryStereoselective SynthesisNatural Product SynthesisAsymmetric CatalysisSynthetic ChemistryBiomolecular Engineering